Carl Hansen, PhD (CEO and President, Director). Carl Hansen is the founding CEO at AbCellera, a therapeutic antibody discovery company that was created based on technology developed in his academic group at UBC where he is an Associate Professor. Through his career he has co-authored over 65 manuscripts in fields of microfluidics, immunology, genomics, and nanotechnology. He is an inventor on more than 50 patents and patent applications related to this work (38 granted) that are represented in 7 commercial microfluidic products. Dr. Hansen has been engaged in technology translation and entrepreneurship since 2002. In addition to leading AbCellera (www.abcellera.com), he is a scientific co-founder of Precision Nanosystems (www.precisionnanosystems.com), an industry leader in next-generation delivery technology for genetic medicines, and previously served on the SAB of Fluidigm corp.
Carl holds a BASc in Engineering Physics & honours Mathematics (University of British Columbia, 2000), and a doctorate in Applied Physics and Biotechnology from Caltech, 2004, where he trained with Chan-Zuckerberg BioHub Director Stephen Quake. Prior to taking his UBC position, Carl trained as a postdoctoral fellow with biotech legend Leroy Hood at the Institute for Systems Biology.